Century Therapeutics (IPSC) Insider Trading & Ownership $1.02 -0.08 (-7.27%) (As of 05:45 PM ET) Add Compare Share Share Insider Trades Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsHeadlinesInsider TradesOptions ChainOwnershipSEC FilingsShort InterestTrends Century Therapeutics (NASDAQ:IPSC) Insider Buying and Selling ActivityCurrentInsider OwnershipPercentage6.80%Number OfInsiders Buying(Last 12 Months)0Number OfInsiders Selling(Last 12 Months)3Amount OfInsider Selling(Last 12 Months)$197,649.70 Get IPSC Insider Trade Alerts Want to know when executives and insiders are buying or selling Century Therapeutics stock? Sign up for InsiderTrades.com's daily newsletter to get the latest insider transactions delivered to your inbox daily. Email Address IPSC Insider Buying and Selling by Quarter Ad Behind the MarketsWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Click to get the name and ticker symbol Century Therapeutics Insider and Congressional Trades History Insiders and Members of Congress Insiders Only Members of Congress Only Transaction Type Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 2 Years 3 Years Time Frame * Start Date * End Date Export to Excel Transaction DateNameTitleBuy/SellNumber of SharesAverage Share PriceTotal TransactionDetails11/4/2024Adrienne FaridInsiderSell1,033$1.23$1,270.59 11/4/2024Douglas CarrSVPSell283$1.23$348.09 8/5/2024Adrienne FaridInsiderSell1,073$1.83$1,963.59 8/5/2024Douglas CarrSVPSell289$1.83$528.87 7/26/2024Gregory RussottiInsiderSell586$2.50$1,465.00 7/23/2024Gregory RussottiInsiderSell200$2.50$500.00 Get Insider Trades Delivered To Your InboxEnter your email address below to receive a concise daily summary of insider buying activity, insider selling activity and changes in hedge fund holdings. 6/20/2024Gregory RussottiInsiderSell5,000$2.84$14,200.00 6/5/2024Gregory RussottiInsiderSell5,000$3.00$15,000.00 5/6/2024Gregory RussottiInsiderSell5,000$3.12$15,600.00 5/3/2024Adrienne FaridInsiderSell913$3.11$2,839.43 5/3/2024Douglas CarrSVPSell257$3.11$799.27 4/22/2024Gregory RussottiInsiderSell5,000$3.10$15,500.00 3/7/2024Adrienne FaridInsiderSell22,831$5.14$117,351.34 2/5/2024Adrienne FaridInsiderSell2,035$3.84$7,814.40 2/5/2024Douglas CarrSVPSell643$3.84$2,469.12 (Data available from 1/1/2013 forward) IPSC Insider Trading Activity - Frequently Asked Questions Who is on Century Therapeutics's Insider Roster? The list of insiders at Century Therapeutics includes Adrienne Farid, Douglas Carr, Gregory Russotti, Luis Borges, and Versant Venture Capital Vi, L.. Learn more on insiders at IPSC. What percentage of Century Therapeutics stock is owned by insiders? 6.80% of Century Therapeutics stock is owned by insiders. Learn more on IPSC's insider holdings. Which Century Therapeutics insiders have been selling company stock? The following insiders have sold IPSC shares in the last 24 months: Adrienne Farid ($131,239.35), Douglas Carr ($4,145.35), Gregory Russotti ($62,265.00), and Luis Borges ($295,201.67). How much insider selling is happening at Century Therapeutics? Insiders have sold a total of 129,356 Century Therapeutics shares in the last 24 months for a total of $492,851.37 sold. Century Therapeutics Key ExecutivesMr. Brent Pfeiffenberger M.B.A.Pharm.D., CEO & DirectorDr. Adrienne Farid Ph.D. (Age 62)COO & Head of Early Development Compensation: $670.29kDr. Gregory Russotti Ph.D. (Age 57)Chief Technology & Manufacturing Officer Compensation: $852.56kMr. Douglas Carr CPAInterim Principal Financial Officer, Senior VP of Finance & Operations and Secretary2 recent tradesMr. Kenneth J. Dow J.D.Senior VP of General CounselDr. Shane Williams Ph.D.Chief People OfficerDr. Hyam I. Levitsky M.D. (Age 66)President of Research & Development Compensation: $502.12kMichael Naso Ph.D.Senior VP of Cell EngineeringDr. Nick Trede M.D.Ph.D., Senior VP & Head of Clinical Development More Insider Trading Tools from MarketBeat Related Companies Cryoport Insider Transactions Neurogene Insider Transactions biote Insider Transactions Voyager Therapeutics Insider Transactions Design Therapeutics Insider Transactions Acelyrin Insider Transactions Canopy Growth Insider Transactions Trevi Therapeutics Insider Transactions Eton Pharmaceuticals Insider Transactions Aquestive Therapeutics Insider Transactions Insider Tracking Tools CEO Purchases/Sales CFO Purchases/Sales Top Insider Buying Stocks Top Insider Selling Stocks Insider Trades Screener Insider Trades Newsletter Congressional Stock Trades Insider Trading By Country U.S. Insider Trading Activity Canadian Insider Trading Activity U.K. Insider Trading Activity Australia Insider Trading Activity Latest Articles AppLovin Insiders Sell Shares: Stock Price Indicated Higher Are 2024’s Top Insider Buys a Good Bet for 2025? Bargains Galore? 3 Stocks With Insider Buying in the MillionsInsiders Keep Buying These Stocks: 2 to Buy, 1 to AvoidZeta Global Holdings Insiders Buy Stock After Short-Report This page (NASDAQ:IPSC) was last updated on 12/23/2024 by MarketBeat.com Staff From Our PartnersAmazon coin set to soar 25X – starting December 16th?This tiny 3-cent crypto just partnered with one of the biggest companies in the world… Amazon. And one team...True Market Insiders | Sponsored$2 Trillion Disappears Because of Fed's Secretive New Move$2 trillion has disappeared from the US government's books. The reason why is a new, secretive move being c...Stansberry Research | SponsoredDid You See Trump’s Bombshell Exec. Order 001?Biden broke it... Now Trump is going to fix it. Starting with "Exec. Order 001."Banyan Hill Publishing | SponsoredWe recommended Palantir in 2021, now we’re recommending this...My research indicates there is only one investment that can meet AI's unprecedented demand for energy.Behind the Markets | SponsoredThe #1 Crypto for AIWe’ve issued an urgent landmark trade alert for a new crypto wonder. So, I decided to give you this heads-u...Weiss Ratings | SponsoredElon Musk’s chilling warning for humanityThe 'invasion' I've discovered has nothing to do with the border crisis. What's happening at our southern bord...The Freeport Society | SponsoredTrump’s Sending THIS Crypto Higher on PurposeDiscover the coin set to explode before 2025! Trump could trigger THIS crypto coin… Crypto 101 Media | SponsoredVideo: Blindfolded Man Gets Into a Cybertruck… What Happens Next Will Shock You“Hi, I’m Jeff Brown… Even though I can’t see a thing… I’m about to get in this Cybertruck and drive up t...Brownstone Research | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added five stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Century Therapeutics, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Century Therapeutics With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
